.png)
.png)
Head of Antiviral Development
Pfizer Inc
Disclosure(s): Pfizer Inc: Employee, Stocks/Bonds
Jennifer Hammond is a virologist with a PhD in Infectious Diseases and Microbiology from the University of Pittsburgh. She has over 20 years experience in anti-viral and anti-infective pharmaceutical development and has held various research, clinical and medical roles within the pharmaceutical industry. Jennifer led the team responsible for the conduct of Phase 2/3 clinical trials of PAXLOVID. She is currently Vice President, Head of Antiviral Development at Pfizer.